STAT August 2, 2024
Good morning, and happy Friday. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalot campus. As you may know from my past entries, I’m no coffee drinker, but here are some newsy items to help wake you up and kick-start your weekend. …
The FDA has approved a cutting-edge treatment for a rare soft tissue cancer, STAT tells us. The therapy equips T cells, an important class of immune cell, to target synovial sarcomas, cancers that can form...
Today's Sponsors
Today's Sponsor